Interaction of natriuretic peptide levels and ejection fraction on outcomes with dapagliflozin and empagliflozin in heart failure

Affiliations

• ¹ Baylor Scott and White Research Institute, Dallas, TX, USA.
• ² Department of Medicine, University of Mississippi School of Medicine, Jackson, MS, USA.
• ³ Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
• ⁴ Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal.
• ⁵ National and Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon, Athens, Greece.
• ⁶ Department of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
• ⁷ Baylor University Medical Center, Dallas, TX, USA.
• ⁸ Imperial College, London, UK.